| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |